3m5l: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
[[Image:3m5l. | [[Image:3m5l.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Crystal structure of HCV NS3/4A protease in complex with ITMN-191=== | ===Crystal structure of HCV NS3/4A protease in complex with ITMN-191=== | ||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_21084633}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 21084633 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_21084633}} | |||
==About this Structure== | ==About this Structure== | ||
3M5L is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Hepatitis_c_virus_subtype_1a Hepatitis c virus subtype 1a]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3M5L OCA]. | 3M5L is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Hepatitis_c_virus_subtype_1a Hepatitis c virus subtype 1a]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3M5L OCA]. | ||
==Reference== | |||
<ref group="xtra">PMID:21084633</ref><references group="xtra"/> | |||
[[Category: Hepacivirin]] | [[Category: Hepacivirin]] | ||
[[Category: Hepatitis c virus subtype 1a]] | [[Category: Hepatitis c virus subtype 1a]] | ||
| Line 29: | Line 38: | ||
[[Category: Serine protease]] | [[Category: Serine protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 22 09:25:14 2010'' | ||
Revision as of 09:12, 22 December 2010
Crystal structure of HCV NS3/4A protease in complex with ITMN-191Crystal structure of HCV NS3/4A protease in complex with ITMN-191
Template:ABSTRACT PUBMED 21084633
About this StructureAbout this Structure
3M5L is a 1 chain structure with sequence from Hepatitis c virus subtype 1a. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Romano KP, Ali A, Royer WE, Schiffer CA. Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding. Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):20986-91. Epub 2010 Nov 17. PMID:21084633 doi:10.1073/pnas.1006370107
Page seeded by OCA on Wed Dec 22 09:25:14 2010